Let me quote what @AJ7 had mentioned long back,
Zip will be in the Yo-Yo trading range until the Spotti and Twisto acquisitions are complete.
- As a LT SH, we want the acquisition to be made at a higher SP which means lesser shares to issue and less dilution to SP
- On the contrary, as an owner of Spotti and Twisto, I want the SP to drop as much as possible so I can grab more shares of Zip.
This is exactly the same situation played last year when the SP was floating in $6-$7 range until all shares of Quadpay were bought. Probably LD and PG have made an agreement with Spotti and Twisto owners to not make any left field announcements that will take the SP higher. Same agreement with BoA perhaps too so that they can build their portfolio gradually.
Now the real question is when the hell the Spotti and Twisto acquisitions are due for completion? Zip SP gives a f.uck all and a middle finger till the accumulation and acquisition is complete.
@AJ7@rezX,@AlphaX, @gops - thoughts?
All in my opinion. DYOR
- Forums
- ASX - By Stock
- ZIP
- Daily Price Movement / General Discussion
Daily Price Movement / General Discussion, page-26931
-
- There are more pages in this discussion • 19,627 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
|
|||||
Last
$1.58 |
Change
-0.120(7.08%) |
Mkt cap ! $1.774B |
Open | High | Low | Value | Volume |
$1.72 | $1.72 | $1.57 | $42.26M | 26.16M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19469 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 33400 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 19469 | 1.575 |
24 | 201490 | 1.570 |
8 | 332978 | 1.565 |
14 | 423682 | 1.560 |
5 | 110775 | 1.555 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 33400 | 3 |
1.585 | 243831 | 7 |
1.590 | 129069 | 8 |
1.595 | 30000 | 2 |
1.600 | 175967 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online